Add to ORKGChimeric antigen receptor (CAR) T-cell therapy is an immunotherapy approach that has played a tremendous role in the battle against cancer for years. Since the CAR T lymphocytes are unrestricted-major histocompatibility complex T lymphocytes, they could identify more targets than natural T cells, resulting in practical and widespread functions. The good prospects of CAR T-cell therapy in oncology can be additionally applied to treat other diseases such as autoimmune and infectious diseases. CAR-T cell-derived immunotherapy for autoimmune disorders can be allocated to CAR-Tregs and chimeric autoantibody receptor T cells. Other generations of CARs target human immunodeficiency virus (HIV) proteins. In this review, we summarize CAR-T cell ther...
This is an adoptive T-cell therapy which uses engineered T-cell. In which they are obtain from a pat...
Chimeric Antigen receptor T cell (CAR-T cell) therapy is a novel adoptive immunotherapy where T lymp...
In the past decade, chimeric antigen receptor (CAR) T cell technology has revolutionized cancer immu...
Adoptive cell transfer (ACT) has long been at the forefront of the battle with cancer that began las...
Infectious diseases are still a significant cause of morbidity and mortality worldwide. Despite the ...
Infectious diseases are still a significant cause of morbidity and mortality worldwide. Despite the ...
Adoptive cell transfer (ACT) has long been at the forefront of the battle with cancer that began las...
Cell-based immunotherapies have made enormous progress over the last decade with the approval of sev...
Cell-based immunotherapies have made enormous progress over the last decade with the approval of sev...
Human immunodeficiency virus type 1 (HIV-1), the virus that causes AIDS (acquired immunodeficiency s...
Chimeric antigen receptor (CAR) T-cells (CAR T-cells) are a promising therapeutic approach in treati...
Chimeric antigen receptors (CAR) T cells are T cells engineered to express membrane receptors with h...
Chimeric antigen receptor T cell (CAR-T cell) therapy is a novel adoptive immunotherapy where T lymp...
Chimeric antigen receptors (CAR) are genetically engineered receptors that can recognise specific an...
According to the growing developments and improvements of cancer immunotherapies, nowadays, special ...
This is an adoptive T-cell therapy which uses engineered T-cell. In which they are obtain from a pat...
Chimeric Antigen receptor T cell (CAR-T cell) therapy is a novel adoptive immunotherapy where T lymp...
In the past decade, chimeric antigen receptor (CAR) T cell technology has revolutionized cancer immu...
Adoptive cell transfer (ACT) has long been at the forefront of the battle with cancer that began las...
Infectious diseases are still a significant cause of morbidity and mortality worldwide. Despite the ...
Infectious diseases are still a significant cause of morbidity and mortality worldwide. Despite the ...
Adoptive cell transfer (ACT) has long been at the forefront of the battle with cancer that began las...
Cell-based immunotherapies have made enormous progress over the last decade with the approval of sev...
Cell-based immunotherapies have made enormous progress over the last decade with the approval of sev...
Human immunodeficiency virus type 1 (HIV-1), the virus that causes AIDS (acquired immunodeficiency s...
Chimeric antigen receptor (CAR) T-cells (CAR T-cells) are a promising therapeutic approach in treati...
Chimeric antigen receptors (CAR) T cells are T cells engineered to express membrane receptors with h...
Chimeric antigen receptor T cell (CAR-T cell) therapy is a novel adoptive immunotherapy where T lymp...
Chimeric antigen receptors (CAR) are genetically engineered receptors that can recognise specific an...
According to the growing developments and improvements of cancer immunotherapies, nowadays, special ...
This is an adoptive T-cell therapy which uses engineered T-cell. In which they are obtain from a pat...
Chimeric Antigen receptor T cell (CAR-T cell) therapy is a novel adoptive immunotherapy where T lymp...
In the past decade, chimeric antigen receptor (CAR) T cell technology has revolutionized cancer immu...